SOLIGENIX, INC. — Investor Relations & Filings
Filings indexed
1,023
across all filing types
Latest filing
2026-05-08
Regulatory Filings
Country
US
United States of America
Listing
US
SNGX
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with unmet medical needs. The company operates through two main segments: Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics pipeline develops treatments for orphan diseases. The Public Health Solutions pipeline, funded by government grants and contracts, focuses on developing vaccines and therapeutics for infectious diseases and biodefense applications, including a program to prevent ricin poisoning.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-08 | English | |
| 424B3 - SOLIGENIX, INC. (0000812796) (Filer) | 2026-05-08 | English | |
| 424B3 - SOLIGENIX, INC. (0000812796) (Filer) | 2026-05-08 | English | |
| 424B3 | 2026-05-08 | English | |
| 10-Q | 2026-05-08 | English | |
| 8-K - SOLIGENIX, INC. (0000812796) (Filer) | 2026-04-28 | English |
Browse filings by year
20 years- 2026 19 filings
- 2025 43 filings
- 2024 51 filings
- 2023 62 filings
- 2022 39 filings
- 2021 37 filings
- 2020 50 filings
- 2019 37 filings
- 2018 40 filings
- 2017 51 filings
- 2016 74 filings
- 2015 45 filings
- 2014 72 filings
- 2013 74 filings
- 2012 30 filings
- 2011 62 filings
- 2010 83 filings
- 2009 87 filings
- 2008 40 filings
- 2007 27 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46108625 | 424B3 | 2026-05-08 | English | ||
| 44412999 | 424B3 - SOLIGENIX, INC. (0000812796) (Filer) | 2026-05-08 | English | ||
| 44412954 | 424B3 - SOLIGENIX, INC. (0000812796) (Filer) | 2026-05-08 | English | ||
| 46108658 | 424B3 | 2026-05-08 | English | ||
| 46108646 | 10-Q | 2026-05-08 | English | ||
| 37970936 | 8-K - SOLIGENIX, INC. (0000812796) (Filer) | 2026-04-28 | English | ||
| 46108626 | Regulatory Filings 2026 | 2026-04-03 | English | ||
| 46108647 | Regulatory Filings 2026 | 2026-04-03 | English | ||
| 46108650 | Regulatory Filings 2026 | 2026-04-03 | English | ||
| 46108653 | Regulatory Filings 2026 | 2026-04-03 | English | ||
| 46108683 | POS AM | 2026-03-31 | English | ||
| 46108724 | POS AM | 2026-03-31 | English | ||
| 46108775 | POS AM | 2026-03-31 | English | ||
| 46108837 | POS AM | 2026-03-31 | English | ||
| 46108913 | 10-K | 2026-03-31 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
SOLIGENIX, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35119/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35119 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35119 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35119 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35119}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SOLIGENIX, INC. (id: 35119)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.